-transparent.png){kind=logo}
The alpha-adrenolytic activity of 1-methyl-10-methoxydihydrolysergol 2-(3,5-dimethyl)pyrrolcarboxylate (XV, formula II) is, both in vitro and parenterally, quite similar to that of dihydroergotamine. By oral route the new compound is more active, and longer lasting than dihydroergotamine.
Related Publications
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
July 1983,
Il Farmaco; edizione scientifica,
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
January 1957,
Journal de physiologie,
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
May 1998,
Bioorganic & medicinal chemistry letters,
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
May 1987,
Drug design and delivery,
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
June 2008,
Die Pharmazie,
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
November 1985,
Bratislavske lekarske listy,
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
February 1982,
Il Farmaco; edizione scientifica,
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
January 1989,
Farmaco (Societa chimica italiana : 1989),
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
February 1968,
Experientia,
L Bernardi, and
G Bosisio, and
M Croci, and
C Elli, and
A Temperilli, and
G Arcari, and
G Falconi, and
A Glaesser
August 2006,
Journal of neurology,
